Dr. Jesse Berlin received his doctorate in biostatistics from the Harvard School of Public Health in 1988. After spending 15 years as a faculty member at the University of Pennsylvania, in the Center for Clinical Epidemiology and Biostatistics, under the direction of Dr. Brian Strom, Jesse left Penn to join Janssen Research & Development, as a Senior Director in Biostatistics. After 2 years, he was promoted to Vice President for Epidemiology. He now serves as Vice President of Epidemiology across all of Johnson & Johnson, with responsibility for pharmaceuticals, devices and consumer products. He has authored or coauthored over 230 publications in a wide variety of clinical and methodological areas, including papers on the study of meta-analytic methods as applied to both randomized trials and epidemiology.
He served on an Institute of Medicine Committee that developed recently-released recommendations for the use of systematic reviews in clinical effectiveness research, and currently serves on the Scientific Advisory Committee to the Observational Medical Outcomes Partnership, a public-private partnership aimed at understanding methodology for assessing drug safety in large, administrative databases. He serves as a member of working group X for CIOMS (The Council for International Organizations of Medical Sciences), which is developing guidelines for meta-analysis of drug safety data in the regulatory context. He was elected as a fellow of the American Statistical Association in 2004. In 2013, Dr. Berlin received the Lagakos Distinguished Alumni Award from the Department of Biostatistics at the Harvard School of Public Health.